首页> 美国卫生研究院文献>Experimental Molecular Medicine >Genomics in neurodevelopmental disorders: an avenue to personalized medicine
【2h】

Genomics in neurodevelopmental disorders: an avenue to personalized medicine

机译:神经发育障碍的基因组学:个性化医学的途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite the remarkable number of scientific breakthroughs of the last 100 years, the treatment of neurodevelopmental disorders (e.g., autism spectrum disorder, intellectual disability) remains a great challenge. Recent advancements in genomics, such as whole-exome or whole-genome sequencing, have enabled scientists to identify numerous mutations underlying neurodevelopmental disorders. Given the few hundred risk genes that have been discovered, the etiological variability and the heterogeneous clinical presentation, the need for genotype—along with phenotype-based diagnosis of individual patients has become a requisite. In this review we look at recent advancements in genomic analysis and their translation into clinical practice.
机译:尽管在过去100年中取得了许多科学突破,但是神经发育障碍(例如自闭症谱系障碍,智力障碍)的治疗仍然是一个巨大的挑战。基因组学的最新进展,例如全外显子组或全基因组测序,已使科学家能够鉴定出神经发育障碍的众多突变。考虑到已发现的数百个风险基因,病因变异性和临床表现的异质性,对基因型的需求以及基于个体患者的基于表型的诊断已成为必要条件。在这篇综述中,我们着眼于基因组分析及其在临床实践中的最新进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号